The Food and Drug Administration in America has ordered a safety review of antibacterial soaps after a new study warned that such products contain ingredients that make humans resistant to antibiotics.
Colleen Rogers, an FDA microbiologist, said that the new data suggests that the risks associated with long-term, daily use of antibacterial soaps may outweigh the benefits as such products may also have "unanticipated hormonal effects that are of concern," the BBC reported.
FDA said in a statement that scientists had tested the effects of chemicals in such products on animals and found that they do indeed alter hormones.
The statement added that it is now important to be check the results on humans because so many people use them.
FDA has asked manufacturers to show evidence that such soaps are safe and more effective against infection than plain soap and water.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
